George W. Rozakis, MD

Dr. Rozakis is a board certified biomedical engineer who studied medicine at Cornell Medical Center and studied Ophthalmology at the Duke Eye Center.

Dr. Rozakis worked in the field of Advanced Wellness for over 15 years. He has applied this science to many conditions but most notably to macular degeneration and patients with migraine. Dr. Rozakis won the advancements in healthcare award in Cleveland, Ohio (beating out the Cleveland Clinic) in 2015 for his work in Advanced Wellness and advocates for this approach to health care to his patients and colleagues.

Dr. Rozakis pioneered the field of Lasik refractive surgery, phakic refractive lenses, and the use of hormones and other advanced testing to treat macular degeneration. He wrote a textbook on refractive surgery and holds multiple patents. He was one of the first surgeons in the world to perform LASIK. In 1998, he was voted by his peers to receive an international award for his contributions to LASIK refractive surgery. Dr. Rozakis published an extensive textbook on refractive surgery that was read throughout the world and even translated into Japanese.


Brian Bakke, PhD

Dr. Bakke serves as a science advisor to the Macular Program. Dr. Bakke holds a PhD in bio-organic chemistry and his thesis work focused on the development of DNA alkylating agents for use as drug delivery systems. His post-doctoral work was focused on the development of iso-adenosine analogues as methylation pathway inhibitors for use as chemotherapeutic agents.

Dr. Bakke also holds a master’s degree in human nutrition from Columbia University. His master’s thesis work focused on studying the clinical nutrition practice patterns used by eye professionals in the prevention and treatment of Age-Related Macular Degeneration (AMD). In conjunction with his master’s thesis work, Dr. Bakke completed a 1-year clinical nutrition program for health professionals through Columbia University Medical Center and the Institute of Human Nutrition.

Prior to partnering with the Macular Program, Dr. Bakke spent 6 years working as chief science officer with a medical consulting company. His work as chief science officer focused on collaborating with primary care physicians in developing personalized nutrition and bioidentical hormone based care plans for improving clinical outcomes for patients with complex medical conditions. Previously, Dr. Bakke spent 7 years working with the multi-national chemistry, biotechnology and life science companies BASF and Syngenta as a senior chemist.